These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23006671)

  • 1. Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study.
    Besson M; Daali Y; Di Lio A; Dayer P; Zeilhofer HU; Desmeules J
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):192-7. PubMed ID: 23006671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
    Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU
    Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia.
    Ralvenius WT; Acuña MA; Benke D; Matthey A; Daali Y; Rudolph U; Desmeules J; Zeilhofer HU; Besson M
    Neuropharmacology; 2016 Oct; 109():366-375. PubMed ID: 27392635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers.
    Besson M; Matthey A; Daali Y; Poncet A; Vuillemier P; Curatolo M; Zeilhofer HU; Desmeules J
    Pain; 2015 Mar; 156(3):397-404. PubMed ID: 25687539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers.
    Matthey A; Daali Y; Curtin F; Poncet A; Desmeules J; Besson M
    Eur J Pain; 2020 Jul; 24(6):1094-1106. PubMed ID: 32171038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer N-phthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain.
    Yogeeswari P; Ragavendran JV; Sriram D; Kavya R; Vanitha K; Neelakantan H
    Pharmacology; 2008; 81(1):21-31. PubMed ID: 17785996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.
    Sankar R
    CNS Drugs; 2012 Mar; 26(3):229-44. PubMed ID: 22145708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
    Bagdas D; Sonat FA; Hamurtekin E; Sonal S; Gurun MS
    Behav Pharmacol; 2011 Sep; 22(5-6):589-98. PubMed ID: 21836465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites.
    Paul J; Yévenes GE; Benke D; Di Lio A; Ralvenius WT; Witschi R; Scheurer L; Cook JM; Rudolph U; Fritschy JM; Zeilhofer HU
    Neuropsychopharmacology; 2014 Jan; 39(2):477-87. PubMed ID: 24045508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV; Cahill CM
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring the spinal pain gate: GABA(A) receptors as targets for novel analgesics.
    Zeilhofer HU; Ralvenius WT; Acuña MA
    Adv Pharmacol; 2015; 73():71-96. PubMed ID: 25637438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology.
    Saari TI; Uusi-Oukari M; Ahonen J; Olkkola KT
    Pharmacol Rev; 2011 Mar; 63(1):243-67. PubMed ID: 21245208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain.
    Rode F; Jensen DG; Blackburn-Munro G; Bjerrum OJ
    Eur J Pharmacol; 2005 Jun; 516(2):131-8. PubMed ID: 15936014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAergic mechanisms are involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia.
    Stepanović-Petrović RM; Tomić MA; Vucković SM; Kocev N; Ugresić ND; Prostran MS; Bosković B
    Pharmacology; 2008; 82(1):53-8. PubMed ID: 18434764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA
    Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM
    Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
    Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND
    Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of peripheral alpha 2-adrenoceptors in the antihyperalgesic effect of oxcarbazepine in a rat model of inflammatory pain.
    Tomić MA; Vucković SM; Stepanović-Petrović RM; Ugresić ND; Paranos SLj; Prostran MS; Bosković B
    Anesth Analg; 2007 Nov; 105(5):1474-81, table of contents. PubMed ID: 17959985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAA receptor modulation in dorsal root ganglia in vivo affects chronic pain after nerve injury.
    Naik AK; Pathirathna S; Jevtovic-Todorovic V
    Neuroscience; 2008 Jul; 154(4):1539-53. PubMed ID: 18554816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.